John Newman
Stock Analyst at Canaccord Genuity
(0.59)
# 4,215
Out of 5,044 analysts
946
Total ratings
40.5%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Reiterated: Buy | $136 | $95.84 | +41.90% | 30 | Oct 12, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $46 | $24.17 | +90.32% | 15 | Oct 12, 2026 | |
| ATRA Atara Biotherapeutics | Reiterated: Buy | $13 | $9.38 | +38.59% | 92 | Oct 1, 2026 | |
| INCY Incyte | Reiterated: Buy | $152 | $111.36 | +36.49% | 2 | Oct 1, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $14 | $1.40 | +900.00% | 39 | Sep 30, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $18 | $5.53 | +225.50% | 34 | Sep 29, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.9375 | +646.67% | 16 | Sep 23, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $50 | $19.60 | +155.10% | 16 | Sep 22, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $23 → $20 | $3.26 | +513.50% | 5 | Sep 9, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $29 | $8.81 | +229.17% | 2 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.01 | +692.08% | 15 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.78 | +155.62% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $15.67 | +34.01% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.9541 | +843.30% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $2.68 | +720.90% | 69 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $17.98 | +61.29% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.04 | +51.76% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 | $762.81 | +14.71% | 118 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.64 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.4733 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $300 | $8.55 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $6.99 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $44 | $30.82 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.0005 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $353.18 | $21.32 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $25.70 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $13.68 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.7849 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.21 | $9.83 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $0.9058 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $6 | $1.45 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $35.81 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $16.55 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $14.46 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $7.95 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $0.7501 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $1.66 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $11.32 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $4.84 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $31.73 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $2.48 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $28.69 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $989.04 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $1.08 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $216.75 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $7.57 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $12.61 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $229.41 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.13 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $62.14 | n/a | 1 | Jun 10, 2009 |
BioNTech SE
Oct 12, 2026
Reiterated: Buy
Price Target: $136
Current: $95.84
Upside: +41.90%
Tango Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $46
Current: $24.17
Upside: +90.32%
Atara Biotherapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $13
Current: $9.38
Upside: +38.59%
Incyte
Oct 1, 2026
Reiterated: Buy
Price Target: $152
Current: $111.36
Upside: +36.49%
Allogene Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $14
Current: $1.40
Upside: +900.00%
Adicet Bio
Sep 29, 2026
Reiterated: Buy
Price Target: $18
Current: $5.53
Upside: +225.50%
Compass Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9375
Upside: +646.67%
Tyra Biosciences
Sep 22, 2026
Reiterated: Buy
Price Target: $50
Current: $19.60
Upside: +155.10%
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $3.26
Upside: +513.50%
Kazia Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.81
Upside: +229.17%
Aug 17, 2026
Reiterated: Buy
Price Target: $8
Current: $1.01
Upside: +692.08%
Aug 13, 2026
Reiterated: Buy
Price Target: $25
Current: $9.78
Upside: +155.62%
Aug 11, 2026
Reiterated: Buy
Price Target: $21
Current: $15.67
Upside: +34.01%
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $0.9541
Upside: +843.30%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $2.68
Upside: +720.90%
Aug 6, 2026
Reiterated: Buy
Price Target: $29
Current: $17.98
Upside: +61.29%
Aug 5, 2026
Reiterated: Buy
Price Target: $38
Current: $25.04
Upside: +51.76%
Jul 22, 2026
Reiterated: Buy
Price Target: $875
Current: $762.81
Upside: +14.71%
Nov 12, 2024
Reiterated: Buy
Price Target: $10
Current: $4.64
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $5
Current: $0.4733
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $6 → $300
Current: $8.55
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $43
Current: $6.99
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $52 → $44
Current: $30.82
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7 → $3
Current: $0.0005
Upside: n/a
May 26, 2021
Reiterated: Buy
Price Target: $353.18
Current: $21.32
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $31
Current: $25.70
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $45
Current: $13.68
Upside: n/a
Mar 25, 2021
Reiterated: Buy
Price Target: $5
Current: $0.7849
Upside: n/a
Mar 9, 2020
Reiterated: Buy
Price Target: $14.21
Current: $9.83
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $0.9058
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $31 → $6
Current: $1.45
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $35.81
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $16.55
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $14.46
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $7.95
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $0.7501
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $1.66
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $11.32
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $4.84
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $31.73
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $2.48
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $28.69
Upside: n/a
Mar 31, 2016
Reiterated: Buy
Price Target: $18
Current: $989.04
Upside: n/a
Mar 9, 2015
Reiterated: Hold
Price Target: $8 → $6
Current: $1.08
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $216.75
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $7.57
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $12.61
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $229.41
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.13
Upside: n/a
Jun 10, 2009
Reiterated: Sell
Price Target: n/a
Current: $62.14
Upside: n/a